SI1095941T1 - Process and crystal forms of 2-methyl-thieno-benzodiazepine - Google Patents

Process and crystal forms of 2-methyl-thieno-benzodiazepine

Info

Publication number
SI1095941T1
SI1095941T1 SI9630636T SI9630636T SI1095941T1 SI 1095941 T1 SI1095941 T1 SI 1095941T1 SI 9630636 T SI9630636 T SI 9630636T SI 9630636 T SI9630636 T SI 9630636T SI 1095941 T1 SI1095941 T1 SI 1095941T1
Authority
SI
Slovenia
Prior art keywords
benzodiazepine
thieno
methyl
crystal forms
crystal
Prior art date
Application number
SI9630636T
Other languages
English (en)
Slovenian (sl)
Inventor
Charles Arthur Bunnell
Barry Arnold Hendriksen
Samuel Dean Larsen
Original Assignee
Eli Lilly & Company
Eli Lilly And Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23621056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1095941(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly & Company, Eli Lilly And Company Limited filed Critical Eli Lilly & Company
Publication of SI1095941T1 publication Critical patent/SI1095941T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
SI9630636T 1995-03-24 1996-03-22 Process and crystal forms of 2-methyl-thieno-benzodiazepine SI1095941T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40956695A 1995-03-24 1995-03-24
EP00203573A EP1095941B1 (de) 1995-03-24 1996-03-22 Verfahren und Kristallformen von 2-Methylthienobenzodiazepinen

Publications (1)

Publication Number Publication Date
SI1095941T1 true SI1095941T1 (en) 2003-12-31

Family

ID=23621056

Family Applications (4)

Application Number Title Priority Date Filing Date
SI9620040A SI9620040B (sl) 1995-03-24 1996-03-22 Postopek in kristalne oblike 2-metil-tieno-benzodiazepina
SI9630743T SI1445259T1 (sl) 1995-03-24 1996-03-22 Uporaba kristalnih oblik 2-metil-tienobenzodiazepina
SI9630345T SI0733635T1 (en) 1995-03-24 1996-03-22 Crystal forms of a thieno(2,3-B)(1,5) benzodiazepine derivative and process for their preparation
SI9630636T SI1095941T1 (en) 1995-03-24 1996-03-22 Process and crystal forms of 2-methyl-thieno-benzodiazepine

Family Applications Before (3)

Application Number Title Priority Date Filing Date
SI9620040A SI9620040B (sl) 1995-03-24 1996-03-22 Postopek in kristalne oblike 2-metil-tieno-benzodiazepina
SI9630743T SI1445259T1 (sl) 1995-03-24 1996-03-22 Uporaba kristalnih oblik 2-metil-tienobenzodiazepina
SI9630345T SI0733635T1 (en) 1995-03-24 1996-03-22 Crystal forms of a thieno(2,3-B)(1,5) benzodiazepine derivative and process for their preparation

Country Status (49)

Country Link
US (1) US5736541A (de)
EP (3) EP0733635B1 (de)
JP (1) JPH11502535A (de)
KR (1) KR100399688B1 (de)
CN (1) CN1065536C (de)
AP (1) AP828A (de)
AR (2) AR010448A1 (de)
AT (4) ATE331719T1 (de)
AU (1) AU706471B2 (de)
BG (1) BG62619B1 (de)
BR (1) BR9607790A (de)
CA (1) CA2214005C (de)
CH (1) CH690579A5 (de)
CO (1) CO4650278A1 (de)
CZ (1) CZ292688B6 (de)
DE (4) DE69636313T2 (de)
DK (4) DK0733635T3 (de)
EA (1) EA000149B1 (de)
EE (1) EE03489B1 (de)
EG (1) EG23659A (de)
ES (3) ES2208220T3 (de)
FI (1) FI973750A (de)
GB (1) GB2313835B (de)
HK (1) HK1013988A1 (de)
HU (1) HU224989B1 (de)
IL (1) IL117610A (de)
IS (1) IS1896B (de)
LT (1) LT4349B (de)
LU (1) LU90096B1 (de)
LV (1) LV12018B (de)
MY (1) MY114701A (de)
NO (1) NO314663B1 (de)
NZ (1) NZ306110A (de)
OA (1) OA10510A (de)
PA (1) PA8353701A1 (de)
PE (1) PE44897A1 (de)
PL (1) PL183723B1 (de)
PT (3) PT1095941E (de)
RO (1) RO118872B1 (de)
SE (1) SE9703205D0 (de)
SI (4) SI9620040B (de)
SK (1) SK284143B6 (de)
SV (1) SV1996000031A (de)
TR (1) TR199701017T1 (de)
TW (2) TW513432B (de)
UA (1) UA44765C2 (de)
WO (1) WO1996030375A1 (de)
YU (1) YU49478B (de)
ZA (2) ZA962344B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
JPH11512705A (ja) * 1995-09-29 1999-11-02 イーライ・リリー・アンド・カンパニー チック症を処置する方法
UA57727C2 (uk) * 1996-03-11 2003-07-15 Елі Ліллі Енд Компані Спосіб лікування надмірної агресивності
EA000769B1 (ru) * 1996-03-25 2000-04-24 Эли Лилли Энд Компани Способ лечения при боли, вызванной мигренью
IL126203A (en) * 1996-03-25 2002-12-01 Lilly Co Eli A synergistic painkiller that contains olenzapine and another painkiller
CN1219878A (zh) * 1996-03-25 1999-06-16 伊莱利利公司 治疗疼痛的方法
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
KR100516088B1 (ko) * 1996-09-23 2005-09-22 일라이 릴리 앤드 캄파니 올란자핀 이수화물 ｄ
DK1155696T3 (da) * 1997-04-15 2004-07-12 Lilly Co Eli Anvendelse af olanzapin til fremstillingen af et medikament til neurobeskyttelse
ZA982917B (en) * 1997-04-15 1999-10-06 Lilly Co Eli Method for treating cerebral focal stroke.
US20030022889A1 (en) * 1997-04-15 2003-01-30 Bymaster Franklin P. Method for providing neuro-protective effects
AU6955998A (en) * 1997-04-15 1998-11-11 Eli Lilly And Company Method for providing neuro-protective effects
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
US6617321B2 (en) * 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
DK1119359T3 (da) * 1998-09-30 2004-08-16 Lilly Co Eli 2-methyl-thieno-benzodiazepinformulering
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
US6348458B1 (en) 1999-12-28 2002-02-19 U & I Pharmaceuticals Ltd. Polymorphic forms of olanzapine
CA2395774C (en) * 1999-12-28 2009-09-15 Cipla Limited New polymorphic forms of olanzapine
CZ2003566A3 (cs) * 2000-08-31 2004-01-14 Dr. Reddy's Laboratories Ltd. Způsob přípravy hydrátů olanzapinu a jejich konverze na krystalické formy olanzapinu
AU2001282913A1 (en) * 2000-09-08 2002-03-22 Eli Lilly And Company A method of treating weight gain associated with atypical antipsychotic use
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
WO2003037903A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CA2471341C (en) * 2001-12-24 2012-01-24 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20050025791A1 (en) * 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
WO2004089313A2 (en) * 2003-04-01 2004-10-21 Transform Pharmaceuticals, Inc. Novel olanzapine forms and related methods of treatment
EP2266590A3 (de) 2002-02-22 2011-04-20 Shire LLC Wirkstoff-Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Wirkstoffen
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
PL196814B1 (pl) * 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
US7297789B2 (en) 2002-05-31 2007-11-20 Sandoz, Inc. Process of preparation of olanzapine form I
SI21270A (sl) * 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
PL202856B1 (pl) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Sposób otrzymywania farmaceutycznie czystej polimorficznej postaci I olanzapiny
EP1575962A1 (de) 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Neue kristallformen von olanzapin, verfahren zu deren herstellung und verfahren zur herstellung bekannter kristallformen von olanzapin
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
ES2232331T1 (es) * 2003-03-12 2005-06-01 Biogal Gyogyszergyar Rt. Procedimientos para la preparacion de formas polimorficas de desloratadina.
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
GB0314149D0 (en) * 2003-06-18 2003-07-23 Generics Uk Ltd Novel amorphous forms
GB0326148D0 (en) 2003-11-10 2003-12-17 Lilly Co Eli Morpholine derivatives
EP1684734A2 (de) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapin-haltige transdermale arzneimittelabgabezusammensetzungen
ATE397611T1 (de) * 2003-12-22 2008-06-15 Teva Pharma Verfahren zur herstellung von olanzapin
AR047459A1 (es) 2004-01-27 2006-01-18 Synthon Bv Sales estables de 2-metil-4-(4-metil-1-piperazinil)-10h-tieno[2,3-b][1,5]benzodiazepina (olanzapina)
US20050272720A1 (en) * 2004-01-27 2005-12-08 Rolf Keltjens Process for making olanzapine Form I
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
CA2587710C (en) * 2004-11-16 2014-10-21 Elan Pharma International Ltd. Injectable nanoparticulate olanzapine formulations
PL1838716T3 (pl) 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
CZ297214B6 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
AR053562A1 (es) * 2005-03-21 2007-05-09 Reddys Lab Ltd Dr Proceso para la preparacion de la forma i cristalina de olanzapina
US20070021605A1 (en) * 2005-07-20 2007-01-25 Rolf Keltjens Process and composition for making olanzapine form i
EP1919923A1 (de) * 2005-08-17 2008-05-14 Synthon B.V. Verfahren zur herstellung von olanzapin form i
GB0522474D0 (en) 2005-11-03 2005-12-14 Actavis Group A pharmaceutical formulation
HUP0501046A2 (en) 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US8721202B2 (en) 2005-12-08 2014-05-13 Ncr Corporation Two-sided thermal print switch
US8367580B2 (en) 2006-03-07 2013-02-05 Ncr Corporation Dual-sided thermal security features
US8222184B2 (en) 2006-03-07 2012-07-17 Ncr Corporation UV and thermal guard
ES2279715B1 (es) 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
US20070293479A1 (en) * 2006-05-18 2007-12-20 Osinga Niels J Olanzapine pharmaceutical composition
AR063043A1 (es) * 2006-09-29 2008-12-23 Synthon Bv Composicion farmaceutica de olanzapina
US7718649B1 (en) 2006-11-10 2010-05-18 Pisgah Labs, Inc. Physical states of a pharmaceutical drug substance
US8039461B1 (en) 2006-11-10 2011-10-18 Pisgah Laboratories, Inc. Physical states of a pharmaceutical drug substance
PL381564A1 (pl) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent Sposób wytwarzania zasadniczo czystej odmiany polimorficznej I olanzapiny
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
US9056488B2 (en) 2007-07-12 2015-06-16 Ncr Corporation Two-side thermal printer
US8883863B1 (en) 2008-04-03 2014-11-11 Pisgah Laboratories, Inc. Safety of psuedoephedrine drug products
CN101735239B (zh) * 2008-11-06 2011-08-31 齐鲁制药有限公司 一种无水奥氮平晶型ii的制备方法
EP2292624A1 (de) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Olanzapinreinigungsverfahren
SI2608670T1 (sl) 2010-08-23 2019-04-30 Alkermes Pharma Ireland Limited Postopki za zdravljenje pridobivanja teže, ki je posledica uporabe antipsihotičnih zdravil
CN102093386B (zh) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 一种制备奥兰扎平晶型ⅱ的方法
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
WO2014031656A1 (en) * 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine haptens and use thereof
PL2888284T3 (pl) 2012-08-21 2023-02-27 Janssen Pharmaceutica Nv Przeciwciała przeciwko haptenom rysperydonu i ich zastosowanie
WO2014031662A2 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine and use thereof
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CN103848847B (zh) * 2012-12-04 2018-02-06 广东东阳光药业有限公司 一种改进制备奥氮平及其晶型ii的方法
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法
CN103145731B (zh) * 2013-02-26 2014-02-19 江苏豪森药业股份有限公司 奥氮平晶型及其制备方法和用途
WO2023139531A1 (en) 2022-01-20 2023-07-27 Teva Pharmaceuticals International Gmbh Olanzapine, compositions thereof and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
IE53696B1 (en) 1981-12-02 1989-01-18 Wyeth John & Brother Ltd Solid shaped articles
US5039540A (en) 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
NO305125B1 (no) * 1992-05-29 1999-04-06 Lilly Industries Ltd Farmas°ytiske forbindelser
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
CA2214005C (en) 2001-07-03
DE69614426D1 (de) 2001-09-20
HUP9802824A2 (hu) 1999-06-28
PL183723B1 (pl) 2002-07-31
ES2208220T3 (es) 2004-06-16
BR9607790A (pt) 1998-07-07
AU5427996A (en) 1996-10-16
DK1095941T3 (da) 2004-02-16
SV1996000031A (es) 1998-03-27
SI9620040B (sl) 2002-02-28
CO4650278A1 (es) 1998-09-03
IL117610A (en) 2001-08-26
SK121897A3 (en) 1998-03-04
IS1896B (is) 2003-10-20
NO974365L (no) 1997-09-22
MX9707183A (es) 1997-11-29
NZ306110A (en) 1998-09-24
TR199701017T1 (xx) 1998-01-21
NO974365D0 (no) 1997-09-22
WO1996030375A1 (en) 1996-10-03
NO314663B1 (no) 2003-04-28
FI973750A0 (fi) 1997-09-22
ES2159346T3 (es) 2001-10-01
IL117610A0 (en) 1996-07-23
GB9719819D0 (en) 1997-11-19
EP1445259A1 (de) 2004-08-11
SE9703205L (sv) 1997-09-05
DE69636313D1 (de) 2006-08-10
HU224989B1 (en) 2006-05-29
GB2313835B (en) 1998-09-16
KR100399688B1 (ko) 2004-02-18
AT406771B (de) 2000-08-25
DK1445259T3 (da) 2006-10-16
SI1445259T1 (sl) 2006-10-31
ZA962342B (en) 1997-09-22
EA000149B1 (ru) 1998-10-29
CZ292688B6 (cs) 2003-11-12
OA10510A (en) 2002-04-24
DE69636313T2 (de) 2007-05-31
AP9701065A0 (en) 1997-10-31
AR010448A1 (es) 2000-06-28
RO118872B1 (ro) 2003-12-30
PE44897A1 (es) 1997-10-22
LU90096B1 (fr) 1997-07-22
BG62619B1 (bg) 2000-03-31
AP828A (en) 2000-04-28
FI973750A (fi) 1997-09-22
CH690579A5 (de) 2000-10-31
DE69630324T2 (de) 2004-07-29
ATE331719T1 (de) 2006-07-15
ATA902196A (de) 2000-01-15
DE19681286T1 (de) 1998-04-02
CN1179160A (zh) 1998-04-15
PA8353701A1 (es) 1998-09-18
PT1445259E (pt) 2006-10-31
JPH11502535A (ja) 1999-03-02
SK284143B6 (sk) 2004-10-05
ZA962344B (en) 1997-09-22
YU17796A (sh) 1999-03-04
EA199700262A1 (ru) 1998-02-26
ATE251627T1 (de) 2003-10-15
UA44765C2 (uk) 2002-03-15
TW513432B (en) 2002-12-11
SI0733635T1 (en) 2002-06-30
SE9703205D0 (sv) 1997-09-05
EE9700232A (et) 1998-04-15
CZ300097A3 (en) 1997-12-17
DE69614426T2 (de) 2002-05-23
TW442488B (en) 2001-06-23
LT97148A (en) 1998-01-26
PL322501A1 (en) 1998-02-02
GB2313835A (en) 1997-12-10
BG101900A (en) 1999-03-31
KR19980703188A (ko) 1998-10-15
SI9620040A (sl) 1998-06-30
CN1065536C (zh) 2001-05-09
PT1095941E (pt) 2004-02-27
EP0733635B1 (de) 2001-08-16
DE69630324D1 (de) 2003-11-13
DK0733635T3 (da) 2001-10-08
EP1095941A1 (de) 2001-05-02
DK108997A (da) 1997-11-12
US5736541A (en) 1998-04-07
EE03489B1 (et) 2001-08-15
MY114701A (en) 2002-12-31
YU49478B (sh) 2006-05-25
EP0733635A1 (de) 1996-09-25
ES2266719T3 (es) 2007-03-01
EG23659A (en) 2007-03-26
HUP9802824A3 (en) 2000-01-28
HK1013988A1 (en) 1999-09-17
ATE204280T1 (de) 2001-09-15
IS4564A (is) 1997-09-22
LV12018B (en) 1998-09-20
LT4349B (lt) 1998-05-25
EP1445259B1 (de) 2006-06-28
AR002719A1 (es) 1998-04-29
LV12018A (lv) 1998-04-20
CA2214005A1 (en) 1996-10-03
PT733635E (pt) 2001-12-28
EP1095941B1 (de) 2003-10-08
AU706471B2 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
GB2313835B (en) Process and crystal forms of 2-Methyl-Thieno-Benzodiazepine
EP0744634A3 (de) Polarisator und seine Herstellung
PL326158A1 (en) Frame and method of making same
HUP9901182A3 (en) Closure and method of making same
EP0867531A4 (de) Verfahren und vorrichtung zur herstellung von einkristallen
ZA946706B (en) Spheroidal crystal sugar and method of making
GB2303240B (en) Structure and operation method of LCD
EP0761718A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
EP0704876A4 (de) Flache anzeige und herstellungsverfahren derselben
EP0766123A4 (de) Optische vorrichtung und verfahren zu ihrer herstellung
PL320340A1 (en) Optical lanses and method of making them
EP0825814A4 (de) Flüssiger rauch mit vermindertem teergehalt und herstellungsmethode
GB9516309D0 (en) Novel compounds and process
EP0761721A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
PL325515A1 (en) Pultry egg and method of producing same
EP0761719A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
GB2297575B (en) Reflective block and method of manufacture
EP0761720A3 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
SG63665A1 (en) Display forming method and display
GB2306039B (en) Light display and method of forming the same
GB2306182B (en) Acoustic material and method of use
GB9512387D0 (en) Ovenized crystal assembly and method of manufacture
GB9504876D0 (en) Compounds and process
AU6754296A (en) Crystal of hydrate and process for preparation thereof
GB9510969D0 (en) Acoustic material and method of use